Mountain Province State College, United Kingdom
Opinion
Evolution of SARS COVID-19 in Patients on Chemotherapy
Author(s): Francesco Nicoldi*
The COVID-19 pandemic caused by SARS-CoV-2 has posed distinct challenges for individuals undergoing chemotherapy, as their compromised immune systems render them susceptible to severe infections. This article explores the evolution of SARS-CoV-2 within this specific patient group, shedding light on the intricate relationship between viral dynamics, immune suppression due to chemotherapy, and potential implications for treatment strategies. Chemotherapy-induced immune suppression prolongs viral persistence and replication, possibly fostering the accumulation of mutations and emergence of new variants. Antiviral treatments exert selective pressure on the virus, potentially driving the development of variants with altered characteristics. This article underscores the importance of ongoing research to elucidate the evolutionary dynamics of SARS-CoV-2 in chemotherapy patients, providing in.. View More»
DOI:
10.35248/2332 2594.23.13(8).520